Evidence map›Paper›PMID 35976430›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2023

Comorbidities complicating heart failure: changes over the last 15 years.

Elles M Screever, Martje H L van der Wal, Dirk J van Veldhuisen, Tiny Jaarsma, Astrid Koops, Kuna S van Dijk, Janke Warink-Riemersma, Jenifer E Coster, B Daan Westenbrink, Peter van der Meer and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Article
  8. One Syndrome, Many Faces: A Unified Perspective on Heart Failure Phenotypes.International journal of molecular sciences · 2025
    Review
  9. Independent predictors of quality of life in patients with chronic heart failure.Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Elles M ScreeverDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Martje H L van der WalDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Dirk J van VeldhuisenDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Tiny JaarsmaDepartment of Social and Welfare Studies, Linköping University, Linköping, Sweden.
Astrid KoopsDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Kuna S van DijkDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Janke Warink-RiemersmaDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Jenifer E CosterDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
B Daan WestenbrinkDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Peter van der MeerDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Rudolf A de BoerDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands.
Wouter C MeijersDepartment of Cardiology, Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, PO Box 30.001, 9700 RB, Groningen, the Netherlands. w.c.f.w.meijers@umcg.nl.
University Medical Center Groningen · NLUniversity of Groningen · NLLinköping University · SE

Funding

Fondation Leducq Cure PhosphoLambaN induced Cardiomyopathy (Cure-PLaN)H2020 European Research Council ERC CoG 818715H2020 European Research Council SECRETE-HFHartstichting CVON DOUBLE DOSEHartstichting CVON PREDICT2Hartstichting CVON RED-CVDHartstichting CVON SHE-PREDICTS-HFHartstichting Dekker grant 03-005-2021-T005Hartstichting grant 2000Z003Hartstichting grant 2017-11Hartstichting grant 2017-21Hartstichting grant 2018-30Hartstichting grant 2020B005Universitair Medisch Centrum Groningen Mandema-Stipendium of the Junior Scientific Masterclass 2020-10
6 · The paper itself

Abstract

aimsManagement of comorbidities represents a critical step in optimal treatment of heart failure (HF) patients. However, minimal attention has been paid whether comorbidity burden and their prognostic value changes over time. Therefore, we examined the association between comorbidities and clinical outcomes in HF patients between 2002 and 2017. METHODS AND

resultsThe 2002-HF cohort consisted of patients from The Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) trial (n = 1,032). The 2017-HF cohort were outpatient HF patients enrolled after hospitalization for HF in a tertiary referral academic hospital (n = 382). Kaplan meier and cox regression analyses were used to assess the association of comorbidities with HF hospitalization and all-cause mortality. Patients from the 2017-cohort were more likely to be classified as HF with preserved ejection fraction (24 vs 15%, p < 0.001), compared to patients from the 2002-cohort. Comorbidity burden was comparable between both cohorts (mean of 3.9 comorbidities per patient) and substantially increased with age. Higher comorbidity burden was significantly associated with a comparable increased risk for HF hospitalization and all-cause mortality (HR 1.12 [1.02-1.22] and HR 1.18 [1.05-1.32]), in the 2002- and 2017-cohort respectively. When assessing individual comorbidities, obesity yielded a statistically higher prognostic effect on outcome in the 2017-cohort compared to the 2002-HF cohort (p for interaction 0.026).

conclusionDespite major advances in HF treatment over the past decades, comorbidity burden remains high in HF and influences outcome to a large extent. Obesity emerges as a prominent comorbidity, and efforts should be made for prevention and treatment. Created with BioRender.com.

Indexed as

Heart FailureClinical Trials as TopicComorbidityHospitalizationHumansObesityPrognosisStroke VolumeComorbiditiesHeart failureHospitalizationMortalityObesity

Identifiers

PMID35976430
PMCPMC9849176
OpenAlexW4292265404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.